Sinogene Biotechnology
Chinese commercial pet cloning — Beijing, 2017-
Launched Commercial cloning services 2017. 500+ pet clones produced. Maintains 1,000+ laboratory beagle breeding base for surrogate infrastructure — physical capacity Western academic research cannot legally maintain.
Per-canine clone cost €20,000-€60,000. Demand driven by Chinese pet-humanization trends + high-net-worth capital + low domestic regulatory friction.
Engine Framing: regulatory-arbitrage substrate node. Apex (b) Institutional-Competition load-bearing — capital seeks path of least resistance; offshore commercial environments absorb the substrate that Western academic regulatory regimes excluded.
Also in Cloning Substrate Post-Dolly
Sooam Biotech Research FoundationSubstrate-continuation commercial node — Seoul, 20ViaGen PetsUS commercial pet cloning — Texas, 2015-Trans Ova GeneticsIndustrial-agricultural SCNT — Iowa, 2002-Mitalipov OHSU Center for Embryonic Cell and Gene TherapyWestern academic human-SCNT + germline node — OregHe Jiankui — Post-Prison Disclosure-Window ProbeCRISPR-babies operator → Hainan post-prison continCAS Shanghai Primate SCNT PipelineState-coordinated primate-cloning substrate monopoColossal BiosciencesOperator-class capital de-extinction substrate — T